These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2880884)

  • 1. Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure.
    Barjon JN; Rouleau JL; Bichet D; Juneau C; De Champlain J
    J Am Coll Cardiol; 1987 Mar; 9(3):622-30. PubMed ID: 2880884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy.
    Kiowski W; Erne P; Pfisterer M; Mueller J; Buehler FR; Burkart F
    Am J Cardiol; 1987 May; 59(12):1118-25. PubMed ID: 3578053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the acute hemodynamic effect of nisoldipine (Bay k 5552) and nifedipine in patients with ischemia-induced left ventricular impaired function].
    Aschenberg W; Nienaber C; Spielmann R; Bleifeld W
    Z Kardiol; 1988 Apr; 77(4):238-44. PubMed ID: 3291444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of nisoldipine in chronic congestive heart failure.
    Vogt A; Kreuzer H
    Arzneimittelforschung; 1983; 33(6):877-9. PubMed ID: 6684444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous nisoldipine in severe congestive heart failure.
    Moe GW; Karlinsky SJ; Frankel D; Armstrong PW
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):160-6. PubMed ID: 2459547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the second-generation calcium channel blocker nisoldipine on left ventricular contractility in cardiac failure.
    Lewis BS; Shefer A; Merdler A; Flugelman MY; Hardoff R; Halon DA
    Am Heart J; 1988 Jun; 115(6):1238-44. PubMed ID: 3376841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure.
    Dei Cas L; Metra M; Ferrari R; Visioli O
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):103-10. PubMed ID: 8097924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative acute effects of the calcium channel blockers tiapamil, nisoldipine, and nifedipine on blood pressure and some regulatory factors in normal and hypertensive subjects.
    Laederach K; Weidmann P; Lauener F; Gerber A; Ziegler WH
    J Cardiovasc Pharmacol; 1986; 8(2):294-302. PubMed ID: 2422467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin.
    Kirch W; Stenzel J; Dylewicz P; Hutt HJ; Santos SR; Ohnhaus EE
    Br J Clin Pharmacol; 1986 Aug; 22(2):155-9. PubMed ID: 3530303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study.
    Schofer J; Hobuss M; Aschenberg W; Tews A
    Eur Heart J; 1990 Aug; 11(8):712-21. PubMed ID: 1975780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salutary hemodynamic and sustained clinical beneficial effects of nisoldipine, a new calcium channel blocker, in patients with recurrent ischemia and severe heart failure.
    Kimchi A; Ellrodt AG; Charuzi Y; Shell W; Murata GH
    Am Heart J; 1985 Aug; 110(2):496-8. PubMed ID: 4025130
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity.
    Mettauer B; Rouleau JL; Bichet D; Kortas C; Manzini C; Tremblay G; Chatterjee K
    Circulation; 1986 Mar; 73(3):492-502. PubMed ID: 3512121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the acute hemodynamic response to intravenous nisoldipine (Bay k 5552) and intravenous nifedipine for left ventricular dysfunction secondary to myocardial infarction.
    Nienaber CA; Spielmann RP; Aschenberg W; Fehr A; Clausen A; Bleifeld W
    Am J Cardiol; 1987 Oct; 60(10):836-41. PubMed ID: 3661397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic effects of nisoldipine (Bay k 5552), a calcium antagonist, in coronary surgery patients].
    Kling D; Boldt J; Moosdorf R; von Bormann B; Hempelmann G
    Anaesthesist; 1986 Oct; 35(10):595-603. PubMed ID: 3789388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal tubular effect of nisoldipine, a calcium channel blocker, in rats.
    Kauker ML; Zeigler DW; Zawada ET
    J Cardiovasc Pharmacol; 1987; 9 Suppl 1():S32-8. PubMed ID: 2441182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the second-generation calcium channel blocking drug nisoldipine on diastolic left ventricular dysfunction in heart failure.
    Lewis BS; Shefer A; Flugelman MY; Merdler A; Halon DA; Hardoff R
    Am Heart J; 1989 Sep; 118(3):505-11. PubMed ID: 2773771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the calcium channel blocker nisoldipine on the progression of chronic renal failure in man.
    Eliahou HE; Cohen D; Hellberg B; Ben-David A; Herzog D; Shechter P; Kapuler S; Kogan N
    Am J Nephrol; 1988; 8(4):285-90. PubMed ID: 3189422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute haemodynamic and neurohumoral effects of intravenous nisoldipine in patients with severe congestive heart failure.
    Erlemeier HH; Kupper W; Bleifeld W
    Eur J Clin Pharmacol; 1990; 38(1):11-5. PubMed ID: 2184040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nisoldipine. Central haemodynamics at rest and during exercise in essential hypertension: acute and chronic studies.
    Omvik P; Lund-Johansen P; Haugland H
    J Hypertens; 1988 Feb; 6(2):95-103. PubMed ID: 3351300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A trial of the calcium antagonist nisoldipine in hypertensive non-insulin-dependent diabetic patients.
    Odigwe CO; McCulloch AJ; Williams DO; Tunbridge WM
    Diabet Med; 1986; 3(5):463-7. PubMed ID: 2951198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.